aiqbench analysis

The announcement pairs SandboxAQ's quantitative AI platform with NVIDIA's BioNeMo framework for drug discovery. Its "fast" and "auditable" claims are vendor positioning, so readers should look for published benchmarks and details on how the audit trail works. The practical question for AI and quantum readers is whether the integration yields reproducible, verifiable model outputs in real pharmaceutical workflows.